tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Calvin Sternick, 15 are a BUY (60%), 10 are a HOLD (40%).
Analyst Calvin Sternick, carries an average stock price target met ratio of 71.11% that have a potential upside of 15.57% achieved within 93 days. Previously, Calvin Sternick worked at JPMORGAN.
Calvin Sternick’s has documented 50 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on USPH, US Physicalrapy at 19-Mar-2025.
Analyst best performing recommendations are on THC (TENET HEALTHCARE).
The best stock recommendation documented was for THC (TENET HEALTHCARE) at 4/19/2023. The price target of $72 was fulfilled within 9 days with a profit of $4.78 (7.11%) receiving and performance score of 7.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 11-Aug-2026
$80
$10.84 (15.67%)
$84
2 months 12 days ago
(11-Aug-2026)
0/4 (0%)
$15.12 (23.30%)
Hold Since 29-Jul-2025
$67
$-2.16 (-3.12%)
$60
2 months 19 days ago
(04-Aug-2026)
6/8 (75%)
$2.93 (4.57%)
68
Buy Since 26-Oct-2017
$79
$9.84 (14.23%)
$68
2 months 20 days ago
(03-Aug-2026)
7/15 (46.67%)
$15.24 (23.90%)
169
Hold Since 30-May-2024
$66
$-3.16 (-4.57%)
2 months 24 days ago
(29-Jul-2026)
3/4 (75%)
$4.18 (6.76%)
372
Buy Since 29-Apr-2026
$80
$10.84 (15.67%)
$75
2 months 24 days ago
(29-Jul-2026)
7/15 (46.67%)
$18.18 (29.41%)
116
